Official Publications Protagonist Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2026-05-12 EDT			5-day change	1st Jan Change
99.95 ^USD	-3.43%		+0.75%	+14.44%

04:24am	Protagonist Therapeutics Insider Sold Shares Worth $5,918,880, According to a Recent SEC Filing	MT
05-06	Wedbush Adjusts Price Target on Protagonist Therapeutics to $118 From $112, Maintains Outperform Rating	MT

No official publication found